MANH Stock Analysis: Manhattan Associates | NASDAQ

Warehouse Management, Transportation Management, Order Management, Supply Chain

Total Rating 73

Safety 86

Buy Signal 1.14

Software - Application
Industry Rotation: +4.2

Market Cap: 11.5B
Avg Turnover: 162M

Risk 3d forecast

Volatility41.3%

VaR 5^th Pctl6.55%

VaR vs Median-3.06%

Reward TTM

Sharpe Ratio-0.06

Rel. Str. IBD75.1

Rel. Str. Peer Group69.8

Character TTM

Beta0.568

Beta Downside0.766

Hurst Exponent0.415

Drawdowns 3y

Max DD60.98%

CAGR/Max DD0.03

CAGR/Mean DD0.06

EPS (Earnings per Share)

EPS CAGR: 13.15%
EPS Trend: 88.5%

Last SUE: 0.76
Qual. Beats: 0

Revenue

Rev. CAGR: 7.84%
Rev. Trend: 96.0%

Last SUE: 4.00
Qual. Beats: 6

Warnings

No concerns identified

Tailwinds

Confidence

Seasonality 11.6 years of data

Jan +3.8% 6

Feb -2.1% 18

Mar -1.1% 15

Apr +2.3% 15

May +2.9% 34

Jun +2.8% 35

Jul +2.1% 17

Aug -0.2% 13

Sep -3.9% 45

Oct -9.0% 56

Nov +6.5% 52

Dec -2.1% 2

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: MANH Manhattan Associates

Manhattan Associates is a U.S.-based software company that develops and sells supply chain, inventory, and omni-channel commerce solutions for enterprise customers. Its product portfolio centers on warehouse management (including the cloud-native Manhattan Active Warehouse Management), transportation management (Manhattan SCALE), and unified order management and store fulfillment (Manhattan Active Omni), supported by a cloud-native technology platform, maintenance, and professional services such as implementation, consulting, training, and the resale of related hardware and peripherals like RFID readers and barcode scanners.

The company sells primarily through direct sales and partnership channels and serves a diverse set of end markets, including retail, consumer goods, food and grocery, logistics service providers, industrial and wholesale, high technology and electronics, life sciences, and government, with operations spanning the Americas, Europe, the Middle East, Africa, and Asia Pacific. Founded in 1990 and headquartered in Atlanta, Georgia, Manhattan Associates is one of the few publicly traded pure-play vendors in the supply chain execution software segment, an enterprise software category that competes with the supply chain modules of larger ERP suites rather than with broad-based application peers.

Headlines to Watch Out For

Cloud transition to Manhattan Active drives subscription revenue mix
Retail and consumer goods IT spending impacts deal pipeline
Competition from SAP and Oracle pressures WMS market share

Piotroski VR-10 (Strict) 7.0

Net Income: 210.2m TTM > 0 and > 6% of Revenue
FCF/TA: 0.57 > 0.02 and ΔFCF/TA 15.87 > 1.0
NWC/Revenue: -0.71% < 20% (prev 7.20%; Δ -7.91% < -1%)
CFO/TA 0.59 > 3% & CFO 414.9m > Net Income 210.2m
Net Debt (-132.2m) to EBITDA (290.0m): -0.46 < 3
Current Ratio: 0.98 > 1.5 & < 3
Outstanding Shares: last quarter (59.5m) vs 12m ago -2.55% < -2%
Gross Margin: 54.65% > 18% (prev 55.82%; Δ -1.17% > 0.5%)
Asset Turnover: 156.1% > 50% (prev 142.0%; Δ 14.02% > 0%)
Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM)

Altman Z'' 3.77

A: -0.01 (Total Current Assets 467.1m - Total Current Liabilities 475.1m) / Total Assets 698.6m
B: 0.28 (Retained Earnings 193.9m / Total Assets 698.6m)
C: 0.39 (EBIT TTM 283.4m / Avg Total Assets 721.7m)
D: 0.29 (Book Value of Equity 157.5m / Total Liabilities 541.1m)
Altman-Z'' = 3.77 = AA

Beneish M -3.09

DSRI: 0.98 (Receivables 218.9m/209.8m, Revenue 1.13b/1.06b)
GMI: 1.02 (GM 55.82% / 54.65%)
AQI: 0.87 (AQ_t 0.23 / AQ_t-1 0.27)
SGI: 1.06 (Revenue 1.13b / 1.06b)
TATA: -0.29 (NI 210.2m - CFO 414.9m) / TA 698.6m)
Beneish M = -3.09 (Cap -4..+1) = AA

What is the price of MANH shares?

As of August 19, 2026, the stock is trading at USD 196.47 with a total of 833,674 shares traded. Over the past week, the price has changed by +0.40%, over one month by +20.39%, over three months by +43.71% and over the past year by -9.40%.

Current recommended Stop Loss: 175.00 (which is 10.9% or 2.4 ATR below the current price).

Is MANH a buy, sell or hold?

Manhattan Associates has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy MANH.

StrongBuy: 5
Buy: 2
Hold: 3
Sell: 0
StrongSell: 0

What are the forecasts/targets for the MANH price?

Analysts Target Price	207	5.4%

Manhattan Associates (MANH) - Fundamental Data Overview as of 16 August 2026

Market Cap USD = 11.5b (11.5b USD * 1.0 USD.USD)
P/E Trailing = 56.3971
P/E Forward = 37.037
P/S = 10.2192
P/B = 72.443
P/EG = 2.3563
Revenue TTM = 1.13b USD
EBIT TTM = 283.4m USD
EBITDA TTM = 290.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 53.9m USD (from shortLongTermDebtTotal, last quarter) (leases 53.9m already included)
Net Debt = -132.2m USD (calculated: Debt 53.9m - CCE 186.1m)
Enterprise Value = 11.4b USD (11.5b + Debt 53.9m - CCE 186.1m)
Interest Coverage Ratio = unknown (Ebit TTM 283.4m / Interest Expense TTM 0.0)
EV/FCF = 28.50x (Enterprise Value 11.4b / FCF TTM 399.2m)
FCF Yield = 3.51% (FCF TTM 399.2m / Enterprise Value 11.4b)
FCF Margin = 35.45% (FCF TTM 399.2m / Revenue TTM 1.13b)
Net Margin = 18.67% (Net Income TTM 210.2m / Revenue TTM 1.13b)
Gross Margin = 54.65% ((Revenue TTM 1.13b - Cost of Revenue TTM 510.7m) / Revenue TTM)
Gross Margin QoQ = 53.20% (prev 55.13%)
Tobins Q-Ratio = 16.28 (Enterprise Value 11.4b / Total Assets 698.6m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 53.9m)
Taxrate = 25.81% (73.1m / 283.4m)
NOPAT = 210.2m (EBIT 283.4m * (1 - 25.81%))
Current Ratio = 0.98 (Total Current Assets 467.1m / Total Current Liabilities 475.1m)
Debt / Equity = 0.34 (Debt 53.9m / totalStockholderEquity, last quarter 157.5m)
Debt / EBITDA = -0.46 (Net Debt -132.2m / EBITDA 290.0m)
Debt / FCF = -0.33 (Net Debt -132.2m / FCF TTM 399.2m)
Total Stockholder Equity = 246.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 29.13% (Net Income 210.2m / Total Assets 698.6m)
RoE = 85.23% (Net Income TTM 210.2m / Total Stockholder Equity 246.7m)
RoCE = 126.7% (EBIT 283.4m / Capital Employed (Total Assets 698.6m - Current Liab 475.1m))
RoIC = 125.7% (NOPAT 210.2m / Invested Capital 167.3m)
WACC = 7.94% (E(11.5b)/V(11.6b) * Re(7.98%) + D(53.9m)/V(11.6b) * Rd(0.0%) * (1-Tc(0.26)))
Discount Rate = 7.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.82 | Cagr: -2.15%
[DCF] Terminal Value 77.97% ; FCFF base≈362.4m ; Y1≈415.5m ; Y5≈611.5m
[DCF] Fair Price = 160.1 (EV 9.20b - Net Debt -132.2m = Equity 9.33b / Shares 58.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 88.46 | EPS CAGR: 13.15% | SUE: 0.76 | # QB: 0
Revenue Correlation: 96.04 | Revenue CAGR: 7.84% | SUE: 4.0 | # QB: 6
EPS current Quarter (2026-09-30): EPS=1.46 | Chg30d=+1.65% | Revisions=+25% | Analysts=11
EPS current Year (2026-12-31): EPS=5.48 | Chg30d=+2.24% | Revisions=+25% | GrowthEPS=+8.3% | GrowthRev=+7.7%
EPS next Year (2027-12-31): EPS=6.12 | Chg30d=+2.74% | Revisions=+25% | GrowthEPS=+11.6% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: +50% (up=3, down=0)